002760.KO Bo Lak
- Market cap
- KRW 58.2B
- P/E
- 22.2x
- P/B
- 1.13x
- ROE
- 5.9%
- Dividend yield
- 0.51%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 002760.KO undervalued?
Graham number002760.KO trades 5.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bo Lak fundamental analysis
No fundamental analysis for Bo Lak yet.
Bo Lak stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bo Lak
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Na-CMC and Ca-CMC; health subsidiary foods, including gree…
Full company profileBo Lak financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bo Lak annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 35.7B | 33.5B | 33.8B | 36.1B | 38.3B | 39.8B | 48.4B | 46.8B | 47.6B | 50.1B | 47.4B |
| Gross Profit | 5.87B | 5.46B | 5.48B | 4.90B | 4.74B | 6.50B | 8.31B | 5.69B | 4.37B | 7.87B | 8.18B |
| Operating Income | 2.03B | 1.28B | 1.32B | 632M | 144M | 1.69B | 3.28B | 506M | -1.79B | 2.23B | 2.48B |
| EBITDA | - | 2.93B | 2.48B | 2.84B | 2.40B | 3.96B | 5.44B | 2.70B | 310M | 4.24B | 5.31B |
| Net Income | 3.03B | 1.24B | 1.11B | 649M | 395M | 1.69B | 3.07B | 858M | -1.51B | 2.34B | 2.95B |
| EPS | - | 21 | 18 | 11 | 6.59 | 28 | 51 | 14 | -25 | 39 | 49 |
| Balance Sheet | |||||||||||
| Total Assets | 53.1B | 51.8B | 53.3B | 55.6B | 54.1B | 56.3B | 60.9B | 57.9B | 59.3B | 59.2B | 58.5B |
| Total Liabilities | 10.4B | 8.61B | 9.55B | 11.7B | 10.1B | 10.8B | 12.5B | 9.15B | 12.6B | 10.5B | 8.77B |
| Shareholders' Equity | 42.7B | 43.2B | 43.8B | 43.9B | 44.0B | 45.5B | 48.4B | 48.8B | 46.7B | 48.7B | 49.7B |
| Cash & Short-term Investments | 5.29B | 3.16B | 3.54B | 2.66B | 2.22B | 1.91B | 3.16B | 3.30B | 3.63B | 7.94B | 7.47B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 5.45B | 706M | 3.38B | 1.46B | 2.03B | 1.18B | 2.55B | 1.52B | 904M | 7.17B | 1.62B |
| Capital Expenditure | 2.44B | 1.11B | 3.70B | 2.47B | 1.79B | 629M | 650M | 569M | 268M | 1.26B | 1.49B |
| Free Cash Flow | - | -405M | -320M | -1.00B | 195M | 549M | 1.90B | 954M | 636M | 5.91B | 125M |
| Ratios | |||||||||||
| ROE | 7.1% | 2.9% | 2.5% | 1.5% | 0.9% | 3.7% | 6.3% | 1.8% | -3.2% | 4.8% | 5.9% |
| ROA | 5.7% | 2.4% | 2.1% | 1.2% | 0.7% | 3.0% | 5.0% | 1.5% | -2.5% | 3.9% | 5.0% |
| Net Profit Margin | 8.5% | 3.7% | 3.3% | 1.8% | 1.0% | 4.3% | 6.3% | 1.8% | -3.2% | 4.7% | 6.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Bo Lak dividends
- Dividend yield
- 0.51%
- Forward dividend
- 7.00 KRW
- Payout ratio
- 12.8%
- Ex-dividend date
- Dec 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 300M | 5.00 | 12.8% |
| 2024 | KRW 300M | 5.00 | - |
| 2023 | KRW 419M | 7.00 | 48.9% |
| 2022 | KRW 300M | 5.00 | 9.8% |
| 2021 | KRW 240M | 4.00 | 14.1% |
| 2020 | KRW 300M | 5.00 | 75.9% |
| 2019 | KRW 300M | 5.00 | 46.2% |
| 2018 | KRW 419M | 7.00 | 37.9% |
| 2017 | KRW 839M | 14 | 67.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 5:1 on Apr 21, 2017.
Who owns Bo Lak
- Insiders 33.55%
- Institutions 0.03%
- Public & others 66.42%
- Shares outstanding 58.6M
- Free float 36.0M
Bo Lak company profile
- Company name
- Bo Lak
- Ticker
- 002760.KO
- ISIN
- KR7002760007
- Exchange
- Korea Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Fiscal year end
- December
- Address
- Chorokro, Hwaseong-si, South Korea, 720-37
- Phone
- 82 3 1352 6455
- Website
- bolak.co.kr
About Bo Lak
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Na-CMC and Ca-CMC; health subsidiary foods, including green tea extracts, soy isoflavones, and ginseng extracts; and food coloring products. It also provides gum base products; cosmetic ingredients; fragrances for use in perfumes, cosmetics, hair products, daily supplies, toilet soaps, candles, and industrial products; and other products, such as sweeteners, surfactants, whitening agents, preservatives, antioxidants, abrasives, thickening agents, thickeners, caffeine, and baking powder. Bolak Company Limited was founded in 1959 and is headquartered in Hwaseong-si, South Korea.
Bo Lak management
3- Mr. Kie-Ryun ChungChief Executive Officer · born 1954
- Dae-Ho HwangboHead of Administration Team and Director · born 1960
- Byung-Cheol KimHead of Production Team and Director · born 1951